Inventor · disambiguated record
Eleni Dokou
Also filed as: DOKOU ELENI
12 granted patents·17 pending applications·213 citations·filing 2004–2024
92Inventor score
Top patents by PatentIndex Score
29 records- 0196US8883206B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2014·Granted Nov 11, 2014·83 cites·10 claims
- 0295US10272046B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2016·Granted Apr 30, 2019·27 cites·23 claims
- 0394US11752106B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2021·Granted Sep 12, 2023·3 cites·20 claims
- 0494US11155533B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Oct 26, 2021·10 cites·13 claims
- 0594US10980746B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2018·Granted Apr 20, 2021·13 cites·25 claims
- 0693US11147770B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2019·Granted Oct 19, 2021·6 cites·22 claims
- 0793US10654829B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2018·Granted May 19, 2020·21 cites·23 claims
- 0893US10206877B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2015·Granted Feb 19, 2019·29 cites·27 claims
- 0992US11951212B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2021·Granted Apr 9, 2024·3 cites·37 claims
- 1092US11179367B2Pharmaceutical compositions for treating cystic fibrosisVERTEX PHARMA·Filed 2019·Granted Nov 23, 2021·18 cites·13 claims
- 1189US2025255819A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1286US12214083B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2023·Granted Feb 4, 2025·0 cites·20 claims
- 1377US2025099425A1Pharmaceutical compositions for treating cystic fibrosisVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1466US2022257564A1Pharmaceutical compositions for treating cystic fibrosisVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1565US2015024047A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 1661US2013224293A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1757US2015246031A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 1851US2015010628A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 1949US2021228489A1Compositions for treating cystic fibrosisVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 2047US2013195797A1High potency formulations of vx-950VERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2145US2004213850A1Sustained release delivery of a thrombin inhibitorFiled 2004·Application pending·0 cites
- 2245US2021069174A1Compositions and methods for treatment of cystic fibrosisVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 2341US2013072440A1Co-crystals and pharmaceutical formulations comprising the sameDOKOU ELENI·Filed 2012·Application pending·0 cites
- 2440US2010081642A1Cb-1 receptor modulator pharmaceutical formulationsDOKOU ELENI·Filed 2009·Application pending·0 cites
- 2539US2012064157A1Pharmaceutical composition and administrations thereofDOKOU ELENI·Filed 2011·Application pending·0 cites
- 2638US2010209496A1Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amideDOKOU ELENI·Filed 2007·Application pending·0 cites
- 2737US2007298099A1Liquid and Semi-Solid Pharmaceutical Formulations for Oral Administration of a Substituted AmidePERESYPKIN ANDREY V·Filed 2005·Application pending·0 cites
- 2836US8541025B2Co-crystals and pharmaceutical formulations comprising the sameDOKOU ELENI·Filed 2011·Granted Sep 24, 2013·0 cites·28 claims
- 2932US2012014912A1Palatable pharmaceutical compositionDOKOU ELENI·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →